| 000 | 01894 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518022359.0 | ||
| 264 | 0 | _c20190503 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1807465116 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParks, Christopher A | |
| 245 | 0 | 0 |
_aBreaking tolerance with engineered class I antigen-presenting molecules. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _c02 2019 |
||
| 300 |
_a3136-3145 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmino Acid Sequence _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen Presentation _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Tolerance |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPeptides _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Receptor Superfamily, Member 7 _ximmunology |
| 700 | 1 | _aHenning, Kalli R | |
| 700 | 1 | _aPavelko, Kevin D | |
| 700 | 1 | _aHansen, Michael J | |
| 700 | 1 | _aVan Keulen, Virginia P | |
| 700 | 1 | _aReed, Brendan K | |
| 700 | 1 | _aStone, Jennifer D | |
| 700 | 1 | _aSchrum, Adam G | |
| 700 | 1 | _aGil, Diana | |
| 700 | 1 | _aKranz, David M | |
| 700 | 1 | _aBordner, Andrew J | |
| 700 | 1 | _aBarry, Michael A | |
| 700 | 1 | _aPease, Larry R | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 116 _gno. 8 _gp. 3136-3145 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1807465116 _zAvailable from publisher's website |
| 999 |
_c29337338 _d29337338 |
||